NF-κB in transplantation: Friend or foe?

Transplant Infectious Disease

Volumn 3, Issue 4, 2001, Pages 212-219

  Tsoulfas, George ^a   Geller, David A ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Gene regulation; Inducible nitric oxide synthase, INOS; Ischemia reperfusion injury; Liver transplantation; NF B; Nitric oxide; Organ rejection; Organ transplantation

Indexed keywords

15 DEOXYSPERGUALIN; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLPREDNISOLONE; OLIGODEOXYRIBONUCLEOTIDE; SALAZOSULFAPYRIDINE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; NOS2A PROTEIN, HUMAN;

ARTICLE; GENE EXPRESSION; GENE THERAPY; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY; SEPSIS; SIGNAL TRANSDUCTION; TRANSPLANTATION; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS C; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

ADENOVIRIDAE; ANIMALS; CYCLOSPORINE; GENE EXPRESSION REGULATION; GENE THERAPY; GRAFT REJECTION; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OLIGODEOXYRIBONUCLEOTIDES; ORGAN TRANSPLANTATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SULFASALAZINE; TACROLIMUS;

EID: 0035544037     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2001.30405.x     Document Type: Article

References (54)

1. Signal transduction through NF-κB
2. Therapeutic approaches for ischemia/reperfusion injury in the liver
3. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of I kappaB degradation
4. Activation of nuclear factor-α during orthotopic liver transplantation in rats is protective and does not require Kupffer cells
5. NF-κB expression during cold ischemia correlates with postreperfusion graft function
6. Myocardial nuclear factor-α activity and nitric oxide production in rejecting cardiac allografts
7. Prolongation of allograft survival using dendritic cells treated with NF-κB decoy oligodeoxyribonucleotides
8. NF kappa B decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts
9. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene
10. Nitric oxide production by bronchoalveolar cells during allograft rejection in the rat
11. Extended preservation and effect of nitric oxide in liver transplantation
12. Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy
13. Role of nitric oxide and superoxide in acute cardiac allograft rejection in rats
14. Effect of extended cold ischemia with UW solution on graft function after liver transplantation
15. The influence of preservation injury on rejection in the hepatic transplant recipient
16. Ischemic type biliary complications after orthotopic liver transplantation
17. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-kappa B
18. Early renal ischemia, with or without reperfusion, activates NF kappa B and increases TNF-alpha bioactivity in the kidney
19. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-κB
20. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF kappa B
21. TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-kappa B
22. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases
23. Severe liver degeneration in mice lacking the I kappa B kinase 2 gene
24. Rapid activation of posthepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver
25. NF-κB prevents apoptosis and liver dysfunction during liver regeneration
26. Impaired liver regeneration in inducible nitric oxide synthase deficient mice
27. Targeting nitric oxide delivery in vivo: Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver
28. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation
29. Modification of vascular responses in xenotransplantation: Inflammation and apoptosis
30. Accomodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment
31. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B
32. Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells
33. NOX 100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance
34. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis
35. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection
36. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis
37. Transcription factors as drug targets: Opportunities for therapeutic selectivity
38. Signal-transduction therapy: A novel approach to disease management
39. Activation of nuclear factor-KB via T cell receptor requires a raf kinase and Ca influx
40. Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients
41. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells
42. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-κB activation in rat hepatocytes
43. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IKB synthesis
44. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids
45. Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB
46. Deoxyspergualin inhibits kappa light chain expression in 7OZ/3 preB cells by blocking lipopolysaccharide-induced NF-kappa B activation
47. Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin
48. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes
49. Xenobiotic immunosuppressive agents: Therapeutic effects in animal models of autoimmune disease
50. Peritransplant tolerance induction with anti-CD3-immunotoxin: A matter of proinflammatory cytokine control
51. Inhibition of cytokine-induced nitric oxide synthase expression by gene transfer of adenoviral IκBα
52. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets
53. Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplantation
54. Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation